Merve Sibel Güngören
Merve Sibel Güngören has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Hikmet Can Çubukçu
Department of Medical Biochemistry , Sincan Training and Research Hospital , Ankara , Türkiye
2 shared publications - Ali Kemal Us
Department of Orthopedics and Traumatology , Ankara University , Ankara , Türkiye
1 shared publication - Ayşe Keven
Akdeniz University School of Medicine, Akdeniz University
1 shared publication - Ayşegül Neşe Çıtak Kurt
Paediatric Neurology Clinic, Ankara Bilkent City Hospital, Ankara, Turkey
1 shared publication - Ayşen Bingöl
Department of Pediatric Pulmonology, Akdeniz University Faculty of Medicine, Antalya, Türkiye
1 shared publication - Deniz Yılmaz
Division of Pediatric Neurology, Department of Pediatrics Ankara Bilkent City Hospital Ankara Türkiye
1 shared publication
Latest Publications
- Open Access
- 11 June 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (12) , 1800
Age- and Sex-Specific Reference Intervals for TSH, FT4, and FT3 Derived from the Turkish Multi-Center Cohort
Background/Objectives: Reference intervals (RIs) for thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3) are essential for accurate interpretation of thyroid function tests. Given the pronounced age- and sex-related biological variability of these analytes, locally derived and population-specific RIs are required. Methods: This multicenter study estimated age- and sex-specific RIs for TSH, FT4, and FT3 using an indirect statistical approach applied to routine laboratory information system data from three hospitals in Ankara, Türkiye. Measurements were performed on Maglumi X8 and X6 analyzers (Snibe Diagnostic, Shenzhen, China) using chemiluminescent immunoassays. Reference intervals were calculated using the refineR algorithm implemented in the R programming language, with Box–Cox or shifted two-parameter (mod) Box–Cox transformations selected according to data distribution. Results: More than 100,000 test results were included after predefined exclusions. In adults (≥18 years), the estimated TSH reference intervals were 0.495–5.83 mIU/L in males and 0.485–6.40 mIU/L in females, with higher upper limits observed in females. Adult FT4 reference intervals were approximately 12.9–21.5 pmol/L, and FT3 intervals were 3.46–6.04 pmol/L in males and 3.46–5.76 pmol/L in females. Pediatric reference intervals for TSH and FT4 were also derived across predefined age categories, demonstrating age-dependent variation. Conclusions: This study establishes age- and sex-stratified reference intervals for TSH, FT4, and FT3 using large multicenter routine laboratory datasets, encompassing both adult and pediatric populations. The findings highlight limitations of manufacturer-provided intervals and support the application of indirect statistical approaches, such as refineR, for local reference interval determination in clinical laboratories.
- 11 June 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (12) , 1800
Open AccessAge- and Sex-Specific Reference Intervals for TSH, FT4, and FT3 Derived from the Turkish Multi-Center Cohort
Background/Objectives: Reference intervals (RIs) for thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3) are essential for accurate interpretation of thyroid function tests. Given the pronounced age- and sex-related biological variability of these analytes, locally derived and population-specific RIs are required. Methods: This multicenter study estimated age- and sex-specific RIs for TSH, FT4, and FT3 using an indirect statistical approach applied to routine laboratory information system data from three hospitals in Ankara, Türkiye. Measurements were performed on Maglumi X8 and X6 analyzers (Snibe Diagnostic, Shenzhen, China) using chemiluminescent immunoassays. Reference intervals were calculated using the refineR algorithm implemented in the R programming language, with Box–Cox or shifted two-parameter (mod) Box–Cox transformations selected according to data distribution. Results: More than 100,000 test results were included after predefined exclusions. In adults (≥18 years), the estimated TSH reference intervals were 0.495–5.83 mIU/L in males and 0.485–6.40 mIU/L in females, with higher upper limits observed in females. Adult FT4 reference intervals were approximately 12.9–21.5 pmol/L, and FT3 intervals were 3.46–6.04 pmol/L in males and 3.46–5.76 pmol/L in females. Pediatric reference intervals for TSH and FT4 were also derived across predefined age categories, demonstrating age-dependent variation. Conclusions: This study establishes age- and sex-stratified reference intervals for TSH, FT4, and FT3 using large multicenter routine laboratory datasets, encompassing both adult and pediatric populations. The findings highlight limitations of manufacturer-provided intervals and support the application of indirect statistical approaches, such as refineR, for local reference interval determination in clinical laboratories.
- 20 March 2026
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
Impact of sample size and data origin on the simulation-based analytical performance specification derivation
Objectives: Indirect clinical outcome-based analytical performance specifications (APS) may offer a feasible alternative to direct studies but raise questions regarding data requirements and transferability. This study aimed to determine the minimum sample size for simulation-driven APS and to investigate the impact of data origin. Methods: We analysed data for six laboratory measurands from four distinct datasets: three Turkish hospitals (Istanbul, Ankara, Van) and the US National Health and Nutrition Examination Survey (NHANES) 2017–2020 dataset. Using the ‘APS Calculator’, we determined APS for measurement uncertainty (MU). The effect of sample size was evaluated by subsampling the Istanbul dataset (n=50,000 to n=500) and calculating the Mean Absolute Percentage Error (MAPE) relative to the baseline (n=50,000) (acceptable <2 %). Precision of APS estimate was evaluated using nonparametric 95 % confidence intervals from simulation results and summarized as relative margin of error (RME; acceptable <10 %). Data-origin effects were assessed by Pearson correlation analysis of APS for MU across the four datasets. Results: A sample size of n=5,000 met stability and precision criteria (MAPE 1.99 %; mean RME 6.86 %), whereas n=2,000 exceeded thresholds (MAPE 2.32 %; mean RME 10.67 %). APS for MU were highly consistent across datasets (Pearson r 0.977–0.994), with the main divergence observed for total folate in NHANES. Conclusions: A minimum sample size of 5,000 results appears sufficient for a reliable simulation-driven APS determination. APS were largely transferable across populations when decision limits and agreement targets were constant, with caution for analytes influenced by population exposure and method selectivity.
- 20 March 2026
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
Impact of sample size and data origin on the simulation-based analytical performance specification derivation
Objectives: Indirect clinical outcome-based analytical performance specifications (APS) may offer a feasible alternative to direct studies but raise questions regarding data requirements and transferability. This study aimed to determine the minimum sample size for simulation-driven APS and to investigate the impact of data origin. Methods: We analysed data for six laboratory measurands from four distinct datasets: three Turkish hospitals (Istanbul, Ankara, Van) and the US National Health and Nutrition Examination Survey (NHANES) 2017–2020 dataset. Using the ‘APS Calculator’, we determined APS for measurement uncertainty (MU). The effect of sample size was evaluated by subsampling the Istanbul dataset (n=50,000 to n=500) and calculating the Mean Absolute Percentage Error (MAPE) relative to the baseline (n=50,000) (acceptable <2 %). Precision of APS estimate was evaluated using nonparametric 95 % confidence intervals from simulation results and summarized as relative margin of error (RME; acceptable <10 %). Data-origin effects were assessed by Pearson correlation analysis of APS for MU across the four datasets. Results: A sample size of n=5,000 met stability and precision criteria (MAPE 1.99 %; mean RME 6.86 %), whereas n=2,000 exceeded thresholds (MAPE 2.32 %; mean RME 10.67 %). APS for MU were highly consistent across datasets (Pearson r 0.977–0.994), with the main divergence observed for total folate in NHANES. Conclusions: A minimum sample size of 5,000 results appears sufficient for a reliable simulation-driven APS determination. APS were largely transferable across populations when decision limits and agreement targets were constant, with caution for analytes influenced by population exposure and method selectivity.
- Open Access
- 30 January 2026
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
A biochemical perspective on bone-implant interface healing after cemented knee arthroplasty: role of serum calcium and ALP
Objectives: Osteointegration at the bone-cement interface is essential for the long-term success of implants following cemented total knee arthroplasty (TKA). This study aims to assess the time-dependent changes in serum calcium (Ca) and alkaline phosphatase (ALP) levels after TKA and to explore their relationship with functional recovery and osteointegration potential. Methods: This prospective study involved 100 patients who underwent primary cemented TKA. Serum Ca and ALP levels were measured before surgery and at postoperative days 1, 3 weeks, 6 weeks, 6 months, and 1 year. Functional outcomes were evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), while pain levels were recorded with a 10-point Visual Analog Scale (VAS). Knee range of motion (ROM) was measured with a goniometer. Correlation and multivariate regression analyses were conducted to assess links between biochemical markers and clinical outcomes. Radiographic osteolysis was evaluated through standard X-rays. Results: Serum Ca levels significantly declined over time (p<0.001), while ALP showed a biphasic pattern. Clinical outcomes, including WOMAC, VAS, and ROM, improved markedly (all p0.05). Conclusions: Although measurable changes in serum calcium and ALP levels are observed following cemented TKA, these parameters demonstrate limited clinical utility as systemic markers of osteointegration or predictors of functional recovery. is warranted to assess implant integration and postoperative bone healing better.
- 30 January 2026
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
Open AccessA biochemical perspective on bone-implant interface healing after cemented knee arthroplasty: role of serum calcium and ALP
Objectives: Osteointegration at the bone-cement interface is essential for the long-term success of implants following cemented total knee arthroplasty (TKA). This study aims to assess the time-dependent changes in serum calcium (Ca) and alkaline phosphatase (ALP) levels after TKA and to explore their relationship with functional recovery and osteointegration potential. Methods: This prospective study involved 100 patients who underwent primary cemented TKA. Serum Ca and ALP levels were measured before surgery and at postoperative days 1, 3 weeks, 6 weeks, 6 months, and 1 year. Functional outcomes were evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), while pain levels were recorded with a 10-point Visual Analog Scale (VAS). Knee range of motion (ROM) was measured with a goniometer. Correlation and multivariate regression analyses were conducted to assess links between biochemical markers and clinical outcomes. Radiographic osteolysis was evaluated through standard X-rays. Results: Serum Ca levels significantly declined over time (p<0.001), while ALP showed a biphasic pattern. Clinical outcomes, including WOMAC, VAS, and ROM, improved markedly (all p0.05). Conclusions: Although measurable changes in serum calcium and ALP levels are observed following cemented TKA, these parameters demonstrate limited clinical utility as systemic markers of osteointegration or predictors of functional recovery. is warranted to assess implant integration and postoperative bone healing better.
- 5 August 2024
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 35 (8) , e14212
Aspergillus‐sensitized asthma in children
Background: Asthma is the most common chronic respiratory disease in childhood. Aspergillus fumigatus sensitivity may be involved in the pathogenesis of asthma by leading to different clinical presentations.Objective: To investigate the demographic, clinical, laboratory, and radiological characteristics of A. fumigatus sensitivity in childhood asthma and identify associated risk factors and diagnostic parameters.Methods: A total of 259 children with asthma were included in the study, 7 (2.7%) with allergic bronchopulmonary aspergillosis (ABPA), 84 (32.4%) with A. fumigatus‐sensitized asthma (Af‐SA), and 168 (64.9%) with A. fumigatus‐unsensitized asthma (Af‐UA).Results: Aspergillus sensitivity was associated with early asthma onset and longer asthma duration. Total IgE level and asthma severity are highest in ABPA and higher in Af‐SA. Absolute eosinophil count was higher, and FEV1 was lower in Af‐SA and ABPA. Aspergillus fumigatus was associated with greater odds of being male (odds ratio [OR], 2.45), having atopic dermatitis (OR, 3.159), Alternaria sensitivity (OR, 10.37), and longer asthma duration (OR, 1.266). The best cut‐off values for detecting A. fumigatus positivity were 363.5 IU/mL for total IgE and 455 cells/μL for absolute eosinophil count. In Af‐SA compared to Af‐UA, centrilobular nodules and peribronchial thickening were more common, and the bronchoarterial ratio was higher.Conclusions: Aspergillus sensitivity is a strong allergic stimulus in asthma, leading to laboratory, structural, clinical, and functional consequences. Af‐SA is a distinct asthma endotype independent of ABPA that is characterized by increased risk of severe clinical presentations and impaired lung function.
- 5 August 2024
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 35 (8) , e14212
Aspergillus‐sensitized asthma in children
Background: Asthma is the most common chronic respiratory disease in childhood. Aspergillus fumigatus sensitivity may be involved in the pathogenesis of asthma by leading to different clinical presentations.Objective: To investigate the demographic, clinical, laboratory, and radiological characteristics of A. fumigatus sensitivity in childhood asthma and identify associated risk factors and diagnostic parameters.Methods: A total of 259 children with asthma were included in the study, 7 (2.7%) with allergic bronchopulmonary aspergillosis (ABPA), 84 (32.4%) with A. fumigatus‐sensitized asthma (Af‐SA), and 168 (64.9%) with A. fumigatus‐unsensitized asthma (Af‐UA).Results: Aspergillus sensitivity was associated with early asthma onset and longer asthma duration. Total IgE level and asthma severity are highest in ABPA and higher in Af‐SA. Absolute eosinophil count was higher, and FEV1 was lower in Af‐SA and ABPA. Aspergillus fumigatus was associated with greater odds of being male (odds ratio [OR], 2.45), having atopic dermatitis (OR, 3.159), Alternaria sensitivity (OR, 10.37), and longer asthma duration (OR, 1.266). The best cut‐off values for detecting A. fumigatus positivity were 363.5 IU/mL for total IgE and 455 cells/μL for absolute eosinophil count. In Af‐SA compared to Af‐UA, centrilobular nodules and peribronchial thickening were more common, and the bronchoarterial ratio was higher.Conclusions: Aspergillus sensitivity is a strong allergic stimulus in asthma, leading to laboratory, structural, clinical, and functional consequences. Af‐SA is a distinct asthma endotype independent of ABPA that is characterized by increased risk of severe clinical presentations and impaired lung function.
- 29 August 2022
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 61 (4) , 570-575
Crossing the chasm: strategies for digital transformation in clinical laboratories
Total testing process in a clinical laboratory is designed to produce useful information for patients and clinicians. The changing landscape of healthcare industry forces clinical laboratory leaders to meet the needs of their stakeholders, maximize operational efficiency and improve overall quality of patient care at the same time. The increasing number of data produced force healthcare services industry to digital transformation. Digital transformation is a process of change which includes finding solutions to novel and unmet requirements of an industry by integrating information, computing, communication and connectivity technologies to minimize the number of low-value tasks and focus on high-value tasks. As the process of digital transformation includes not only the modernization of IT infrastructure but also a paradigm shift in perception of value creation and delivery to improve the quality and cost-effectiveness of laboratory operations in the long run, financial, managerial, and educational issues have been blocking the widespread implementation. Clinical laboratories are at the crossroads on the road to the future. Laboratories that fail to align themselves with data-driven practices will risk losing a competitive advantage. In this review, strategies for a successful digital transformation will be overviewed in the context of clinical laboratory settings.
- 29 August 2022
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 61 (4) , 570-575
Crossing the chasm: strategies for digital transformation in clinical laboratories
Total testing process in a clinical laboratory is designed to produce useful information for patients and clinicians. The changing landscape of healthcare industry forces clinical laboratory leaders to meet the needs of their stakeholders, maximize operational efficiency and improve overall quality of patient care at the same time. The increasing number of data produced force healthcare services industry to digital transformation. Digital transformation is a process of change which includes finding solutions to novel and unmet requirements of an industry by integrating information, computing, communication and connectivity technologies to minimize the number of low-value tasks and focus on high-value tasks. As the process of digital transformation includes not only the modernization of IT infrastructure but also a paradigm shift in perception of value creation and delivery to improve the quality and cost-effectiveness of laboratory operations in the long run, financial, managerial, and educational issues have been blocking the widespread implementation. Clinical laboratories are at the crossroads on the road to the future. Laboratories that fail to align themselves with data-driven practices will risk losing a competitive advantage. In this review, strategies for a successful digital transformation will be overviewed in the context of clinical laboratory settings.
- Open Access
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 1640-1646
Impact of COVID-19 on serum melatonin levels and sleep parameters in children
Background/aim: This study aimed to analyze the serum melatonin levels and changes in sleep patterns in pediatric patients with coronavirus disease 2019 (COVID-19). Materials and methods: This study was designed as a descriptive, cross-sectional study. Serum melatonin levels and sleep parameters of children with the diagnosis of COVID-19 who had mild and moderate disease (i.e., COVID-19 group) were compared with those of children admitted with non-COVID-19 nonspecific upper respiratory tract infection (i.e., control group). The sleep disturbance scale for children (SDSC) questionnaire was applied to the participants single right angle bracket primary caregivers to analyze their sleep patterns at present and six months before symptom onset and to investigate the impact of COVID-19 on sleep patterns. Results: The entire study cohort consisted of 106 patients. The COVID-19 group included 80 patients, while the control group consisted of 26 patients. The mean serum melatonin levels were 136.72 pg/mL and 172.63 pg/mL in the COVID-19 and control groups, respectively (p = 0.16). There was no significant difference between the groups in terms of 6 subcategories of the SDSC questionnaire regarding the present time and 6 months before symptom onset. The total SDSC scores were also similar in two different evaluation time points described above (p = 0.99). Conclusions: We conclude that COVID-19 did not impact the sleep parameters of children. Serum melatonin levels of all patients were higher than the reference range; however, they were higher in the non-COVID-19 patient group than the COVID-19 group. Since serum melatonin levels were higher than the reference values in children with COVID-19, and this disease is significantly less morbid in children, melatonin may have protective effects against COVID-19.
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 1640-1646
Open AccessImpact of COVID-19 on serum melatonin levels and sleep parameters in children
Background/aim: This study aimed to analyze the serum melatonin levels and changes in sleep patterns in pediatric patients with coronavirus disease 2019 (COVID-19). Materials and methods: This study was designed as a descriptive, cross-sectional study. Serum melatonin levels and sleep parameters of children with the diagnosis of COVID-19 who had mild and moderate disease (i.e., COVID-19 group) were compared with those of children admitted with non-COVID-19 nonspecific upper respiratory tract infection (i.e., control group). The sleep disturbance scale for children (SDSC) questionnaire was applied to the participants single right angle bracket primary caregivers to analyze their sleep patterns at present and six months before symptom onset and to investigate the impact of COVID-19 on sleep patterns. Results: The entire study cohort consisted of 106 patients. The COVID-19 group included 80 patients, while the control group consisted of 26 patients. The mean serum melatonin levels were 136.72 pg/mL and 172.63 pg/mL in the COVID-19 and control groups, respectively (p = 0.16). There was no significant difference between the groups in terms of 6 subcategories of the SDSC questionnaire regarding the present time and 6 months before symptom onset. The total SDSC scores were also similar in two different evaluation time points described above (p = 0.99). Conclusions: We conclude that COVID-19 did not impact the sleep parameters of children. Serum melatonin levels of all patients were higher than the reference range; however, they were higher in the non-COVID-19 patient group than the COVID-19 group. Since serum melatonin levels were higher than the reference values in children with COVID-19, and this disease is significantly less morbid in children, melatonin may have protective effects against COVID-19.